Cargando…

Intra‐ and inter‐laboratory agreement of the FAM19A4/mir124‐2 methylation test: Results from an international study

BACKGROUND: HPV‐based cervical screening detects women at an increased risk of cervical cancer and precancer. To differentiate among HPV‐positive women those with (pre)cancer, triage testing is necessary. The detection of cancer‐associated host‐cell DNA methylation (FAM19A4 and hsa‐mir124‐2) in cerv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Floore, Arno, Hesselink, Albertus, Oštrbenk, Anja, Alcaniz, Elia, Rothe, Beate, Pedersen, Helle, Torres Hortal, Montserrat, Doorn, Saskia, Quint, Wim, Petry, Karl Ulrich, Poljak, Mario, Cuschieri, Kate, Bonde, Jesper, de Sanjosé, Silvia, Bleeker, Maaike, Heideman, Daniëlle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528594/ https://www.ncbi.nlm.nih.gov/pubmed/30758084 http://dx.doi.org/10.1002/jcla.22854

Ejemplares similares

Methylation markers FAM19A4 and miR124‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study
por: Bonde, Jesper, et al.
Publicado: (2020)

FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study
por: Vink, Frederique J., et al.
Publicado: (2019)

FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years
por: Vink, Frederique J, et al.
Publicado: (2022)

Classification of high‐grade cervical intraepithelial neoplasia by p16(ink4a), Ki‐67, HPV E4 and FAM19A4/miR124‐2 methylation status demonstrates considerable heterogeneity with potential consequences for management
por: Vink, Frederique J., et al.
Publicado: (2021)

Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening
por: Heideman, Daniëlle A. M., et al.
Publicado: (2022)

Direct bisulphite conversion of cervical samples for DNA methylation analysis
por: Verhoef, Lisanne, et al.
Publicado: (2021)

Role of FAM19A4/miR124-2 methylation analysis in predicting regression or non-regression of CIN2/3 lesions: a protocol of an observational longitudinal cohort study
por: Kremer, Wieke W, et al.
Publicado: (2019)

Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/miR124-2 DNA Methylation (CONCERVE Study)
por: Kremer, Wieke W., et al.
Publicado: (2022)

Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework
por: Bhatia, Ramya, et al.
Publicado: (2023)

Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women
por: De Strooper, Lise M.A., et al.
Publicado: (2016)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping
por: Dick, Stèfanie, et al.
Publicado: (2021)

Identification and Characterization of FAM124B as a Novel Component of a CHD7 and CHD8 Containing Complex
por: Batsukh, Tserendulam, et al.
Publicado: (2012)

Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124‐2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions
por: Leeman, Annemiek, et al.
Publicado: (2020)

Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain
por: Poljak, Mario, et al.
Publicado: (2021)

Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
por: Xu, Lan, et al.
Publicado: (2018)

Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up
por: De Strooper, Lise M.A., et al.
Publicado: (2018)

Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel
por: Polman, N. J., et al.
Publicado: (2017)

FAM20A binds to and regulates FAM20C localization
por: Ohyama, Yoshio, et al.
Publicado: (2016)

Stratified Mucin-Producing Intraepithelial Lesion (SMILE) of the Uterine Cervix: High-Risk HPV Genotype Predominance and p40 Immunophenotype
por: Strojan Fležar, Margareta, et al.
Publicado: (2021)

Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework
por: Dhillon, Sharonjit K., et al.
Publicado: (2021)

Assessment of Acceptability and Determinants of Uptake and Schedule Completion of Human Papillomavirus (HPV) Vaccine by 25 to 45 Years Old Women in Slovenia
por: Mlakar, Jana, et al.
Publicado: (2023)

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
por: Bonde, Jesper Hansen, et al.
Publicado: (2020)

Coraliomargarita parva sp. nov., isolated from mangrove sediment and genome-based analysis of the class Opitutae revealed five novel families: Coraliomargaritaceae fam. nov., Pelagicoccaceae fam. nov., Cerasicoccaeae fam. nov., Oceanipulchritudinaceae fam. nov., and Alterococcaeae fam. nov.
por: Min, Lingli, et al.
Publicado: (2023)

FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase
por: Guan, Jikui, et al.
Publicado: (2015)

Climacocystaceae fam. nov. and Gloeoporellaceae fam. nov., two new families of Polyporales (Basidiomycota)
por: Liu, Shun, et al.
Publicado: (2023)

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women
por: Luttmer, Roosmarijn, et al.
Publicado: (2016)

FamAgg: an R package to evaluate familial aggregation of traits in large pedigrees
por: Rainer, Johannes, et al.
Publicado: (2016)

Manufacturers’ views on outcome-based agreements
por: Barjestehvan Waalwijk van Doorn-Khosrovani, Sahar, et al.
Publicado: (2021)

Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape
por: Snellenberg, Suzanne, et al.
Publicado: (2012)

TreeFam: 2008 Update
por: Ruan, Jue, et al.
Publicado: (2008)

Identification of a Novel Human Papillomavirus, Type HPV199, Isolated from a Nasopharynx and Anal Canal, and Complete Genomic Characterization of Papillomavirus Species Gamma-12
por: Oštrbenk, Anja, et al.
Publicado: (2015)

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019)

FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)

Process driven patient tracks in FAM
por: Hansen-Nord, Michael, et al.
Publicado: (2010)

Structure and evolution of the Fam20 kinases
por: Zhang, Hui, et al.
Publicado: (2018)

Tricladiaceae fam. nov. (Helotiales, Leotiomycetes)
por: Johnston, P.R., et al.
Publicado: (2020)

Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory
por: Poljak, Mario, et al.
Publicado: (2023)

Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma
por: Guo, Xing Rong, et al.
Publicado: (2019)

Assessing Agreement between miRNA Microarray Platforms
por: Bassani, Niccolò P., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6iadpsvr72sep0jlmoc99b65no